By the Numbers

Look for floating-rate CMBS backed by stronger properties

Mary Beth Fisher, PhD | September 30, 2022

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

Commercial real estate CLOs and single-asset-single-borrower deals are among the best options for investors looking for a combination of commercial real estate exposure, yield, duration and expected performance, even in a modest downturn in the economy. CRE CLOs and SASB deals allow investors to avoid the volatility of long-duration, fixed-rate securities while the Fed is raising rates and focus on property types with more ability to withstand a down cycle.

CRE CLOs: wider spreads but favorable exposure to multifamily

The new issue market for all types of commercial mortgage-backed securities slowed during the summer and then mostly evaporated in late September as rate volatility increased and spreads widened, and issuance of CRE CLOs has been especially thin. Only three new issue CRE CLO deals have priced since the end of June, though discount margins seemed to be consolidating at the early summer levels across ‘AAA’ to ‘A’ classes (Exhibit 1).

Exhibit 1: New issue CRE CLO spreads (‘AAA’ to ‘A’ classes)

Note: Discount margins on date of new issue pricing. Benchmark rate is either 1-month term or 30-day compound average SOFR.
Source: Bloomberg, Amherst Pierpont Securities

Only one of the three deals issued since June included pricing of ‘BBB’ to ‘BB’ tranches, and the issuer likely retained those classes (Exhibit 2). The published pricing indicates a significant tightening in the discount margin of the D and E classes. With 1-month term SOFR currently just above 3.00% and projected to rise as the Fed continues to raise rates, the coupons on some recently issued ‘BBB’ CRE CLOs are running between 7% and 8%.

Exhibit 2: New issue CRE CLO spreads (‘BBB’ to ‘BB’ classes)

Note: Discount margins on date of new issue pricing. Benchmark rate is either 1-month term or 30-day compound average SOFR.
Source: Bloomberg, Amherst Pierpont Securities

There is some additional risk in owning CRE CLOs versus other products in the CMBS universe, as the properties are in transition. They are typically undergoing a substantial renovation, repositioning or repurposing. However, according to the latest Commercial Real Estate Finance Council (CREFC) Update on CRE Debt Marketplace:

“Of the outstanding CRE CLO universe, over 65% consists of loans secured by multifamily, many of which are older, naturally occurring affordable housing (NOAH) properties that accommodate lower-income tenant.”

The fundamental outlook for multifamily is very strong over the next five to 10 years given the longstanding issue of underbuilding. And the affordable sector of multifamily has by far the largest shortfall in supply. Even during a downturn, this overweight of multifamily should temper any potential losses in affected CRE CLO deals from this particular exposure.

Spreads in SASB vary across property types

The discount margins (DM) for single-asset, single-borrower deals vary by property type (Exhibit 3), with industrial, self-storage and multifamily properties typically being the tightest. The discount margins on recent new SASB issues for these stronger property types have been around 400 bp for the usually ‘BBB’ D tranche. Retail and hospitality properties have the widest DMs at issue, and neither has seen a SASB deal come to market since late spring (retail) or early summer (hospitality). Both sectors face the double whammy of having been badly hurt during the pandemic, and also tend to be among the worst performers during economic downturns.

Exhibit 3: New issue SASB spreads (BBB rated D class)

Note: Discount margins on date of new issue pricing. Benchmark rate is either 1-month term or 30-day compound average SOFR. Deals where property type is either mixed use or not identified are not included.
Source: Bloomberg, Amherst Pierpont Securities

The underlying collateral for SASB deals is a loan for a single property, or a portfolio of properties owned by the same borrower. These are typically institutional borrowers with significant capital resources, and the assets tend to be high quality, trophy properties. That is one reason why recent SASB deals backed by office properties have come at very tight levels despite the downturn in the sector—trophy office continues to do quite well.

SASB classes that are equivalently rated to CRE CLO classes tend to have a bit more credit enhancement across the stack (Exhibit 4). The average discount margins are in the same range, but again, this varies a lot by property type for SASB deals. Both CRE CLOs and these floating-rate SASBs have had yields ranging from 5.50% for ‘AAA’ classes to 7.50% for ‘BBB’ tranches as of mid-September. Those DMs have likely widened out over the past two weeks.

Exhibit 4: Comparison of CRE CLO and floating-rate SASB new issues

Note: Discount margins on date of new issue pricing. Benchmark rate is either 1-month term or 30-day compound average SOFR. The D and E classes of the CRE CLO priced 9/8/2022 were likely retained by the issuer.
Source: Bloomberg, Amherst Pierpont Securities

CRE CLOs and SASB deals help investors get commercial real estate exposure without picking up significant interest rate exposure, too. Spreads look attractive, and significant multifamily exposure in CRE CLOs should strengthen the prospects for good credit. SASB has become largely a market for trophy properties, and that should help credit, too.

Mary Beth Fisher, PhD
marybeth.fisher@santander.us
1 (646) 776-7872

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.